Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giorgio Patelli
Observed name:
G. Patelli
Institutions:
University of Milan,
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda,
IFOM
Observed institutions:
University of Milan,
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda,
IFOM,
Italian Association for Cancer Research
ORCID:
0000-0001-8697-2158
Observed ORCID:
0000-0001-8697-2158
OpenAlex ID:
A5016097866
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment
2022
·
P. Conte
, P.A. Ascierto
, et al.
·
ESMO Open
·
238
PDF
The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives
2022
·
Giorgio Patelli
, Annalisa Zeppellini
, et al.
·
Cancer Treatment Reviews
·
94
Strategies to tackle RAS-mutated metastatic colorectal cancer
2021
·
G. Patelli
, F. Tosi
, et al.
·
ESMO Open
·
86
PDF
Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities
2020
·
Gianluca Mauri
, Viviana Gori
, et al.
·
Cancer Treatment Reviews
·
78
Liquid biopsy for rectal cancer: A systematic review
2019
·
Daniela Massihnia
, Elio Gregory Pizzutilo
, et al.
·
Cancer Treatment Reviews
·
46
Tumor “age” in early-onset colorectal cancer
2025
·
Gianluca Mauri
, Giorgio Patelli
, et al.
·
Cell
·
42
Early-onset cancers: Biological bases and clinical implications
2024
·
Gianluca Mauri
, Giorgio Patelli
, et al.
·
Cell Reports Medicine
·
42
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer
2023
·
Giorgio Patelli
, Gianluca Mauri
, et al.
·
Clinical Cancer Research
·
41
PDF
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
2021
·
Giorgio Patelli
, Caterina Vaghi
, et al.
·
Targeted Oncology
·
35
PDF
Total neoadjuvant therapy followed by non-operative management or surgery in stage II–III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial
2025
·
Alessio Amatu
, Giorgio Patelli
, et al.
·
The Lancet Oncology
·
27
Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: A systematic review
2025
·
Edoardogregorio Galli
, Giorgio Patelli
, et al.
·
Cancer Treatment Reviews
·
27
The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review
2022
·
Caterina Vaghi
, Gianluca Mauri
, et al.
·
Cancer Treatment Reviews
·
27
Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment
2021
·
Alessio Amatu
, Arianna Pani
, et al.
·
European Journal of Cancer
·
24
PDF
Clinical utility and future perspectives of liquid biopsy in colorectal cancer
2025
·
Giorgio Patelli
, Luca Lazzari
, et al.
·
Communications Medicine
·
17
PDF
Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers
2024
·
Gianluca Mauri
, Giorgio Patelli
, et al.
·
Journal of Clinical Pathology
·
16
PDF
Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer
2024
·
Laura Roazzi
, Laura Roazzi
, et al.
·
Clinical Colorectal Cancer
·
15
Immunocytokines in cancer treatment: A systematic review
2025
·
Stefano Agliardi
, Chiara Veronese
, et al.
·
Cancer Treatment Reviews
·
12
509O Total neoadjuvant treatment (TNT) with non-operative management (NOM) for proficient mismatch repair locally advanced rectal cancer (pMMR LARC): First results of NO-CUT trial
2024
·
A. Amatu
, M.G. Zampino
, et al.
·
Annals of Oncology
·
12
PDF
Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies
2025
·
Caterina Vaghi
, Federica Tosi
, et al.
·
Drugs
·
11
PDF
Application of histology-agnostic treatments in metastatic colorectal cancer
2022
·
Andrea Sartore-Bianchi
, Alberto Giuseppe Agostara
, et al.
·
Digestive and Liver Disease
·
11
Clinical Actionability of Genes in Gastrointestinal Tumors
2025
·
Nadia Saoudi Gonzalez
, Giorgio Patelli
, et al.
·
Genes
·
7
PDF
Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer
2022
·
Gianluca Mauri
, Giorgio Patelli
, et al.
·
Frontiers in Oncology
·
5
PDF
Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report
2023
·
Gianluca Mauri
, Viviana Gori
, et al.
·
World Journal of Surgical Oncology
·
4
PDF
Seroconversion after SARS-CoV-2 mRNA booster vaccine in cancer patients
2022
·
Giorgio Patelli
, Arianna Pani
, et al.
·
European Journal of Cancer
·
4
PDF
Impact of chemotherapy on humoral and cellular immune responses to COVID-19 vaccination in patients with solid tumors
2025
·
Andrea Favalli
, Giorgio Patelli
, et al.
·
Frontiers in Immunology
·
3
PDF
Show more works
View as search
Works count:
41
Citation count:
952
H-index:
15
I10-index:
21
Year
Topic
Type